跳至主要内容
临床试验/NCT03783208
NCT03783208已完成不适用

Intrauterine G-CSF Administration in Recurrent Implantation Failure

Gurgan Clinic1 个研究点 分布在 1 个国家目标入组 157 人开始时间: 2018年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
157
试验地点
1
主要终点
Clinical pregnancy rate

研究概览

简要总结

Aim of this study is to investigate the effects of intrauterine G-CSF on endometrial thickness, clinical pregnancy rate and live birth rate in a recurrent implantation failure (RIF) group

详细描述

This study was designed as a prospective randomized controlled trial with the involvement of 200 RIF group patients.The procedure will perform by administering 30 mIU of Leucostim®(Filgrastim [G-CSF] 30mIU/mL; DEM Medical, Dong-A; South Korea) through slow infusion into the endometrial cavity using a soft embryo transfer catheter. Normal saline of 1 mL will be infused into the endometrial cavity in the same way in the control group. The standard ICSI procedure will use for all patients, and fresh cycle embryos will be transferred on the third or fifth day.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women under the age of 40 who met the RIF definition
  • Follicle-stimulating hormone (FSH) levels were <15 IU/mL

排除标准

  • Patients with congenital uterine anomalies
  • Patients with Asherman's syndrome
  • Patients with uterine cavity distorted by myoma or endometrial polyps
  • Patients with confirmed endometriosis or endometrioma
  • Patients for whom G-CSF was contraindicated (active infections, kidney disease, sickle cell anemia, malignancies, chronic neutropenia)

研究组 & 干预措施

G-CSF

Experimental

Patients in the G-CSF group will receive G-CSF once a day on hCG day, before hCG injection. The procedure involved the administration of G-CSF through slow infusion into the endometrial cavity using a soft embryo transfer catheter.

干预措施: G-CSF (Drug)

Control group

Placebo Comparator

Normal saline of 1 mL was infused into the endometrial cavity in the same way in patients in the control group

干预措施: Saline (Other)

结局指标

主要结局

Clinical pregnancy rate

时间窗: 1month

Gestational sac in USG per embryo transfer

次要结局

  • Endometrial thickness(1month)

研究者

发起方
Gurgan Clinic
申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验